medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2007, Number 3

<< Back Next >>

Acta Med 2007; 5 (3)

Actualization in the study and treatment of nocturnal primary enuresis

Gordillo de ARJ

Language: Spanish
References: 27
Page: 141-148
PDF size: 95.95 Kb.


ABSTRACT

Nocturnal enuresis is not a nosological entity but a clinical sign present in an heterogeneous group of diseases. It constitutes a health problem of wide distribution, because it is present in all civilizations and geographic areas, it affects all ethnic groups and social stratums with some preponderance for the less economically suited stratums. At five years of age it affects 15% of children of both genders with a predominance of 3:1 in males and with slightly predominance in left-handeness. In United States is calculated that from 5 to 7 millions of children suffer from primary nocturnal enuresis. In Mexico there are no exact statistics but taking into account the information given by the 2000 XII population’s census directed by The National Institute for Statistics, Geography and Informatics there are in Mexico 2 million 886 thousand five years old children from those 15% or 337,633 suffer form enuresis and considering the total population of children between 5 to 16 years old (26 millions, 31 mil 931), its is quite possible that in our country there could be around 4 to 5 millions of children and youngsters suffering from this medical problem which not only affects the patient’s health both physically and emotionally but also affects his own family and the society around him.


REFERENCES

  1. Cendron M. Primary nocturnal enuresis: current concepts. Am Family Phys 1999; 59: 1205-1224.

  2. Instituto Nacional de Estadística Geografía e Informática. XII Censo General de Población y Vivienda 2000. Tabulados básicos Tomo I 2000: 40-50. México.

  3. Skoog JS. Editorial: Primary nocturnal enuresis - an analysis of factors related to its etiology. J Urol 1998; 159: 1338-1339.

  4. Tietjen DN, Husman DA. Nocturnal enuresis: a guide to evaluation and treatment. Mayo Clin Proc 1996; 71: 852-857.

  5. 5. Von Gontard A, Shaumburg H, Hollman E et al. The genetics of enuresis: a review. J Urol 2001; 166: 2438-2443.

  6. Murphy MA. Preliminary data indicating a relationship between primary nocturnal enuresis and handness. J Pediatr and Child Health (in press).

  7. Hussman DA. Enuresis. Urology (in press).

  8. Ritting S, Knudsen UB, Norgaard JP, Pedrerson EB, Djurhuus JC. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol 1989; 256: F664-F671.

  9. Baruzzi A, Riva R, Cirignota F, Zucconi M, Cappelli M, Lugaresi E. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep 1991; 14: 83-86.

  10. Nureddin VM, Ramazan Y, Akin Y, Zeki A, Serdar T, Can B. Hypernatruria and kaluresis in enuretic children and diurnal variations. J Urol 1998; 159: 1333-37.

  11. Jarveiim MR. Developmental history and neurological findings in enuretic children. Dev Med Child Neurol 1989; 31: 728-736.

  12. Von Gontard A, Schmelzer D, Seifen S, Fukrop R. Central nervous system involvement in nocturnal enuresis: Evidence of general neuromotor delay and specific brainstem dysfunction. J Urol 2001; 166: 2448-2451.

  13. Kalra VY, Palaksha HK. Incidental spine bifida occult in functional enuresis observed during laser reflexotherapy. J Child Neurol 1999; 14(8): 541-543.

  14. Mikelsen EJ, Ropoport JL. Enuresis: psychopathology, sleep stage and drug response. Urol Clin North Am 1980; 7: 361-377.

  15. Weider DJ, Satela MJ, West RP. Nocturnal enuresis in children with upper airway obstruction. Otoralyngol Head Neck Surg 1991; 105: 427-432.

  16. Von Gontard A, Mauer-Mucke K, Pluck J, Berner W, Lehmkuhl G. Clinical behavioral problems in day- and night-wetting children. Pediatr Nephrol 1999; 13(8): 662-667.

  17. Farhat W, Bagli DJ, Capolicchio G et al. The dysfunctional voiding scoring system: Quantitative standardization of dysfunctional voiding symptoms in children. J Urol 2000; 164: 1011-1015.

  18. Norgaard JP, van Gool K, Hjälmäs JC, Djurhuus, Hellström AL. Standardization in lower urinary tract dysfunction in children. Br J Urol 1981; 81(s3): 1-16.

  19. Bauer SB. Neurogenic dysfunction of the lower urinary tract in children. In: Walsh, Retik, Baughan, Wein A. editors. Campbells’ urology. 7th edition. W.B. Saunders Co.; Hard Court Brace and Co., Volume 2 Chapter 65 pages. 2019-2053.

  20. Ritchey M, Bloom DA, Casale AJ, Wan J. Voiding dysfunction in children. Memories of the 94th Annual Meeting of the American Urological Association. Inc. Dallas Texas, pages. 3-24, 05/04/99.

  21. Jensen IN, Kristensen G. Alarm treatment analysis of response and relapse. Scan J Urol 1999; 202(Suppl.): 73-75.

  22. Schulman SL, Stokes A, Salzman PM. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis. J Urol 2001; 166: 2427-2431.

  23. Neveus T. Oxybutinin, desmopressin and enuresis. J Urol 2001; 166: 2459-2462.

  24. Fritz GK, Rockney RM, Yeung AS. Plasma levels and efficacy of imipramine treatment for enuresis. J Am Child Adolesc Psychiatry 1994; 33(1): 6064.

  25. De Grazia E, Cimador M. Oxybutinin-desmopressin association in the treatment of primary nocturnal enuresis with diurnal urination disorders. Minerva Pediatr 1999; 51(5): 149-152.

  26. Tahmaz L, Kibar Y, Yildirim I, Ceylan S, Dayanc M. Combination therapy of imipramine with oxybutinine in children with enuresis nocturnal. Urologia Internationalis 2000; 65(3): 135-139.

  27. Yamanishi T, Yasuda K, Hamano S, Murayama N, Sakakibara R et al. Urethral obstruction in patients with night time wetting, urodynamic evaluation and outcome of surgical incision. Neurourol Urodyn 2000; 19(3): 241-248.




2020     |     www.medigraphic.com